Skip to main content

Find Clinical Trials

Home
Conditions
Pneumococcal Infections

Clinical trial condition

Pneumococcal Infections

Explore clinical trials studying Pneumococcal Infections. Study availability and eligibility vary by location and protocol.

118 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Pneumococcal Infections trial results

Completed

Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso

NCT01577771

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: CSPS Accart-Ville Bobo-Dioulasso, Region Des Hauts Bassins, Burkina Faso

Centre Muraz Bobo-Dioulasso, Region Des Hauts-Bassins, Burkina Faso

CSPS Farakan Bobo-Dioulasso, Region Des Hauts-Bassins, Burkina Faso

CSPS Guimbi Bobo-Dioulasso, Region Des Hauts-Bassins, Burkina Faso

View Trial Details

Completed

Pneumococcal Reference Standard

NCT00479323

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: University of Iowa Iowa City, Iowa, United States

View Trial Details

Completed

Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

NCT02079207

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: Not specified

View Trial Details

Completed

Influenza Vaccine and Pneumococcal Vaccine

NCT02582047

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations: Korea University Ansan Hospital Ansan, Kyoungido, South Korea

Hallym University Gangnam Sacred Hospital Seoul, South Korea

View Trial Details

Completed

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

NCT01444352

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +11 more
Locations: Allschwil, Switzerland

View Trial Details

Completed

A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

NCT00127153

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

NCT00962780

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: Pfizer Investigational Site Bucharest, Romania

Pfizer Investigational Site Bucharest, Romania

Pfizer Investigational Site Constanța, Romania

Pfizer Investigational Site Johannesburg, Gauteng, South Africa

View Trial Details

Completed

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

NCT00744263

Conditions: 13-valent Pneumococcal Vaccine, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations: Pfizer Investigational Site Tilburg, North Brabant, Netherlands

Pfizer Investigational Site Abbekerk, Netherlands

Pfizer Investigational Site Alkmaar, Netherlands

Pfizer Investigational Site Alkmaar, Netherlands

View all 159 locations

View Trial Details

Completed

MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

NCT02225327

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations: Not specified

View Trial Details

Completed

PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers

NCT00714064

Conditions: Acute Otitis Media, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Menzies School of Health Research Darwin, Northern Territory, Australia

View Trial Details